> Bristol-Myers has broken ground on a $660 million drug plant in central Massachusetts. Report
> Canada's Lorus Therapeutics says it has signed an agreement with6707157 Canada to recapitalize and reorganize Lorus' business which, if completed, will result in the addition of approximately $7.8 million in non-dilutive financing. Release
> Oscient Pharmaceuticals has won the FDA's approval to add a new indication for Factive. It can now be used to treat mild to moderate community-acquired pneumonia. Release
> BioServe has acquired Genomics Collaborative from SeraCare Life Sciences. Release
> Robert Bosch GmbH plans to acquire Pharmatec GmbH from Fresenius. Report
> Paladin Labs' subsidiary Squire Pharmaceuticals has inked a pact to acquire a total of eight products currently marketed in Canada by Shire BioChem. Report
> Pfizer and Eisai say that their anti-clotting drug Fragmin has been given an additional approval by the FDA to reduce blood clots in cancer patients. Release
> ThromboGenics has updated investors on its pipeline development work. Release
> India's Strides Arcolab has terminated a deal with Accu-Break Pharmaceuticals to develop generic drugs for the U.S. market. Report
And Finally... Researchers have teamed up with Google Earth to create a map that tracks the spread of avian flu. Report